Abaris Biotechnology Opportunities A USD
| MVD-Fonds Rating | EDA |
|---|---|
![]() ![]() ![]() ![]() ![]() ![]() | - |
ISIN: LU2210105313 | WKN: A2QAAR
KAG: Hauck & Aufhäuser
NAV: 98,31 USD am 15.07.2026
Chart
Kennzahlen Abaris Biotechnology Opportunities A USD
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | +16,70% | +11,46% | +64,10% | +99,65% | +2,80% | - | -11,21% |
| Volatilität | +25,05% | +31,01% | +31,47% | +36,85% | +39,88% | - | +38,93% |
| Sharpe Ratio | +22,05 | +0,71 | +1,96 | +0,64 | -0,05 | - | -0,12 |
| Bester Monat | - | +16,53% | +19,19% | +38,41% | +38,41% | - | +38,41% |
| Schl. Monat | - | -11,55% | -11,55% | -17,12% | -25,72% | - | -25,72% |
| Max. Verlust | -5,76% | -17,46% | -20,04% | -46,01% | -68,74% | - | -75,23% |
Monatsperformance Abaris Biotechnology Opportunities A USD
| 2026 | 2025 | 2024 | 2023 | 2022 | |
| Januar | -1,23% | +4,52% | -1,75% | +15,67% | -25,72% |
| Februar | -1,80% | -5,69% | +38,41% | -7,95% | +3,45% |
| März | -11,55% | -9,80% | -6,39% | -9,99% | +3,48% |
| April | +10,84% | +1,47% | -13,54% | +4,17% | -20,26% |
| Mai | +3,74% | +7,13% | -0,76% | +4,20% | -16,00% |
| Juni | +16,53% | +2,46% | -3,14% | -1,41% | +6,47% |
| Juli | -1,05% | +6,71% | +11,81% | +3,73% | +11,18% |
| August | - | +3,34% | +0,22% | -8,69% | +0,90% |
| September | - | +9,90% | -0,74% | -10,28% | -6,68% |
| Oktober | - | +9,71% | +1,71% | -17,12% | -0,79% |
| November | - | +19,19% | +1,75% | +22,41% | -5,98% |
| Dezember | - | -2,43% | -13,53% | +32,47% | +1,78% |
| Gesamt | +13,74% | +53,12% | +5,30% | +17,13% | -43,64% |



Vortrag am FONDS professionell KONGRESS

Portfolio
Watchlist
Kursalarm